Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gayathri Ravi

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Treatment and Research Communications|February 12, 2022
Current approach to Waldenström MacroglobulinemiaGayathri Ravi, Prashant Kapoor
American Journal of Hematology|June 15, 2022
Bispecific T-cell engagers for treatment of multiple myelomaGayathri Ravi, Luciano J Costa
British Journal of Haematology|October 20, 2025
Reversing the sequence: Efficacy of BCMA-directed therapy following progression on GPRC5D-directed therapies in relapsed multiple myelomaLaura Joiner, Smith Giri, Gayathri Ravi, et al.
British Journal of Haematology|January 31, 2024
Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinationsGayathri Ravi, Susan Bal, Laura Joiner, et al.
The American Journal of Emergency Medicine|October 3, 2018
Protamine sulfate for the reversal of enoxaparin associated hemorrhage beyond 12 hBrian R Lauer, Richard A Nelson, John H Adamski, et al.
Blood|April 7, 2025
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myelomaSmith Giri, Binod Dhakal, Natalie S Callander, et al.
Transplantation and Cellular Therapy|June 14, 2024
Hospital Associated Disability among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell TransplantKyle Kidwell, Susan Bal, Kelly Godby, et al.
Blood Cancer Journal|April 23, 2025
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapySusan Bal, Tylan Magnusson, Gayathri Ravi, et al.
Journal of Geriatric Oncology|May 7, 2024
Understanding health outcome preferences of older adults diagnosed with multiple myelomaSupriya Maheshwari, Miguel Arias, Clare Ubersax, et al.
Blood Advances|October 28, 2025
Impact of body mass index on the prognosis of patients with newly diagnosed Multiple MyelomaKevin D Arnold, Krystle L Ong, Gayathri Ravi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Treatment and Research Communications|February 12, 2022
Current approach to Waldenström MacroglobulinemiaGayathri Ravi, Prashant Kapoor
American Journal of Hematology|June 15, 2022
Bispecific T-cell engagers for treatment of multiple myelomaGayathri Ravi, Luciano J Costa
British Journal of Haematology|October 20, 2025
Reversing the sequence: Efficacy of BCMA-directed therapy following progression on GPRC5D-directed therapies in relapsed multiple myelomaLaura Joiner, Smith Giri, Gayathri Ravi, et al.
British Journal of Haematology|January 31, 2024
Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinationsGayathri Ravi, Susan Bal, Laura Joiner, et al.
The American Journal of Emergency Medicine|October 3, 2018
Protamine sulfate for the reversal of enoxaparin associated hemorrhage beyond 12 hBrian R Lauer, Richard A Nelson, John H Adamski, et al.
Blood|April 7, 2025
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myelomaSmith Giri, Binod Dhakal, Natalie S Callander, et al.
Transplantation and Cellular Therapy|June 14, 2024
Hospital Associated Disability among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell TransplantKyle Kidwell, Susan Bal, Kelly Godby, et al.
Blood Cancer Journal|April 23, 2025
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapySusan Bal, Tylan Magnusson, Gayathri Ravi, et al.
Journal of Geriatric Oncology|May 7, 2024
Understanding health outcome preferences of older adults diagnosed with multiple myelomaSupriya Maheshwari, Miguel Arias, Clare Ubersax, et al.
Blood Advances|October 28, 2025
Impact of body mass index on the prognosis of patients with newly diagnosed Multiple MyelomaKevin D Arnold, Krystle L Ong, Gayathri Ravi, et al.
Pageof 2